Applied Therapeutics shares are trading lower after the company announced that the FDA extended the review period for the NDA for govorestat for the treatment of Classic Galactosemia by three months.

Applied Therapeutics -1.41%

Applied Therapeutics

APLT

4.19

-1.41%

Applied Therapeutics shares are trading lower after the company announced that the FDA extended the review period for the NDA for govorestat for the treatment of Classic Galactosemia by three months.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via